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Objective: The aim of this systematic review was to merge 
and summarize the current evidence about prognostic fac-
tors relevant to the course of complex regional pain syn-
drome 1.
Methods: MEDLINE, Embase, PsychINFO, CENTRAL and 
screened reference lists of included studies were searched for 
studies of parameters associated with the prognosis of the 
condition. Studies investigating stroke-related complex re-
gional pain syndrome were excluded.
Results: Searches retrieved 2,577 references, of which 12 ar-
ticles were included in the study. The preferred diagnostic 
criteria were the Veldman and the International Association 
for the Study of Pain criteria. The mean level of study qual-
ity was insufficient. A total of 28 prognostic factors was iden-
tified. Sensory disturbances and cold skin temperature ap-
pear to represent parameters associated with poor prognosis 
in complex regional pain syndrome 1. For many parameters 
the evidence is contradictory.
Conclusion: Evidence about prognostic factors for complex 
regional pain syndrome 1 is scarce, which prevents firm con-
clusions being drawn. Further high-quality aetiological and 
clinical research is needed.
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INTRODUCTION
Complex regional pain syndrome (CRPS) type 1 is a syndrome 
with significant morbidity and loss of quality of life (1, 2). 
It usually appears after a noxious event, such as trauma or 
surgery (3), and the clinical manifestations include sensory, 
autonomic, motor and trophic changes (4). Despite increasing 
research into CRPS, the exact underlying mechanisms of this 
syndrome are unknown. In a recent review article, Marinus et 
al. (5) concluded that compelling evidence implicates biologi-
cal pathways that underlie aberrant inflammation, vasomotor 
dysfunction, and maladaptive neuroplasticity in the clinical 
features of CRPS. In contrast to CRPS type 2, which is char-
acterized by a definable nerve lesion, CRPS type 1, formerly 
known as reflex sympathetic dystrophy or algodystrophy, ap-
pears without a definable nerve lesion (4). 
Clinical experience suggests that every patient should 
be treated early and aggressively in the hope of preventing 
chronicity. Treatment is empirical and usually includes a 
multidisciplinary approach using a combination of pharma-
cological, physical, occupational and psychological therapies 
(6). However, clinical observation reveals that, in a substantial 
proportion of patients, resolution occurs spontaneously or the 
natural course is benign (7), sometimes even without treatment. 
However, on the other hand, a subgroup of patients with CRPS 
1 will experience an unfavourable course of the disease, with 
consequent high healthcare costs. If this subgroup of patients 
could be identified at an early stage, i.e. with prognostic instru-
ments, treatment activities could be focused and specifically 
tailored to fit the needs of these patients. 
Until now, evidence regarding prognostic aspects of CRPS 
1 has not been assessed systematically. The literature is scat-
tered and not easy to access. Therefore, the purpose of this 
systematic review was to merge and summarize the current 
evidence about prognostic factors relevant for the course of 
CRPS 1. For this study, prognostic factors were defined as all 
clinical and non-clinical parameters with relevant impact on 
clinical course and treatment response, reflected by persisting 
impairment, disease duration and long-term disability. 
METHODS
Literature search 
The search methodology was carried out according to the MOOSE 
statement (Fig. 1) on conducting a meta-analysis of observational 
studies in epidemiology (8). All observational studies investigating 
prognostic factors of CRPS 1, published between 1990 and July 
2011, were identified by searching the following databases: MED-
LINE (OvidSP), MEDLINE In-Process Citations (OvidSP), Embase 
(OvidSP), Embase (OvidSP), PsychINFO and the Cochrane Database 
of Systematic Reviews (CDSR). Searches were restricted to 1990 
onwards, because the current definition of CRPS was introduced in 
the early 1990s (4). The search was conducted with the help of an 
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search, and all (inclusion and exclusion criteria applied) potential 
studies were additionally included.
Study selection, data extraction and synthesis
The bibliographic details of all retrieved articles were stored in an 
Endnote file. Two reviewers (MW and FB) independently screened 
all references by title and abstract. We selected observational studies 
investigating prognostic parameters of CRPS 1. We did not apply any 
language restrictions. Studies investigating stroke-related CRPS 1 
were excluded. All included references were independently reviewed 
in full text (MW and FB). During the screening and inclusion process 
all disagreements were discussed between the two reviewers and 
resolved by consensus. A designated third author (LMB) arbitrated 
any disagreement and facilitated consensus. Based on this review we 
extracted and catalogued all reported prognostic factors and data on 
salient clinical features. For any abstract where the full text was not 
available, the author was contacted.
Alternative researchers with specific language proficiencies were 
used for non-English language references. For descriptive purposes 
and to weight the included studies, study quality was assessed accord-
ing to the proposed guidelines for assessing Quality in Prognostic 
Studies (9) in a two-step approach. Two reviewers (FB and MW) first 
individually compiled the fully operationalized, prognostic factors 
(correlation between the prognostic factor and the outcome). Secondly, 
these prognostic factor responses were tested for each of 6 potential 
biases: representative study population, drop out, adequate measure-
ment of the prognostic factor, outcome measurement, confounding 
measurement and account, and analysis. Reviewers discussed the 
independent ratings and sought consensus about the overall risk of 
bias. A summary is reported in Table II. No quality score was used, 
as recommended by Hayden et al. (9). As the included studies did 
not allow a statistical synthesis of outcome measures, quality criteria 
were used for descriptive purposes only and not for exclusion criteria. 
Synthesis of quality was categorized as good (good for all 6 potential 
biases), acceptable (at least partly fulfilling all 6 criteria) and poor.
RESULTS
Study selection
Fig. 1 shows the study selection process and agreement on 
study inclusion. Our search retrieved 2,577 records, from which 
64 were identified for full review based on title and abstract. 
Full text assessment utilizing inclusion and exclusion criteria 
resulted in the exclusion of 52 studies. The main reasons for 
exclusion were study design (clinical trials) and outcome 
measures (no prognostic factors investigated). In total, 12 
studies fulfilled the inclusion criteria (7, 10–20).
Study characteristics
The study characteristics are summarized in Table III. In total, 
2,246 subjects (median number of subjects 74, range 16–1,006) 
were investigated. Symptom duration ranged from less than 3 
months (11) to more than 8 years (18).
Four studies followed a prospective study design (11, 14, 
15, 18). With the exception of 1 study (14), the prospective 
studies, included fewer patients (n = 16–47, mean 28) compared 
with those with a retrospective design (n = 42–199, mean 98).
Based on the quality assessment, quality was good in 4, 
acceptable in 1 and poor in 9 studies (Table III).
The preferred diagnostic criteria were the Veldman criteria 
(21) (n = 5 (11, 16–19)) and the International Association for the 
experienced information specialist working in the field of systematic 
reviews. Search terms included, in addition to medical subject head-
ings (MeSH terms), all commonly used terms for CRPS (e.g. complex 
regional pain syndrome(s), reflex sympathetic dystrophy, Sudeck’s 
atrophy, algodystrophy, shoulder hand syndrome). A detailed search 
strategy is depicted in Table I. To ensure the completeness of the 
literature search, the reviewers, experienced researchers in the field 
of CRPS, screened bibliographies of all included studies, retrieved 
review articles and current treatment guidelines in an additional hand 
Table I. Search strategy Medline (OvidSP) (1990–2011/07/wk 27)
Search Results
1 complex regional pain syndromes/ or reflex sympathetic 
dystrophy/
3,520 
2 (CRPS 1 or CRPS or complex regional pain syndrome$ 
or RND).ti,ab.
1,823 
3 (reflex$ sympathetic dystroph$ or sudeck$ atroph$ or 
algodystroph$ or algoneurodystroph$).ti,ab.
2,065 
4 (algo dystroph$ or algo neurodystroph$).ti,ab. 13 
5 (shoulder hand syndrom$ or shoulder hand dystroph$).
ti,ab.
259 
6 cervical sympathetic dystroph$.ti,ab. 0 
7 or/1–7 5,017 
8 animals/ not (animals/ and humans/) 10,061 
9 8 not 9 5,015 
10 prognosis/ or exp treatment outcome/ 769,448 
11 (outcome$ or predict$ or prognosis or recover$ or 
remission or relaps$ or deteriorat$ or exacerbat$ or 
worsen$ or course$).ti,ab.
2,146,668 
12 (Cure$ or curative$ or resolv$ or resolution$ or heal$ 
or improv$ or recuperat$).ti,ab.
2,498,217 
13 (convales$ or alleviat$ or decreas$ or lessen$).ti,ab. 1,408,991 
14 or/11–14 5,273,995 
15 10 and 15 1,869 
16 limit 16 to yr=“1990 –Current“ 1,648 
Fig. 1. Study flow.  
 
 
 
Number of additional records
identified through other sources
n=12
Number of records identified 
through database searching:
Medline    n=1,648
Medline In-Process n=   195
Embase    n=1,431
PsychInfo    n=   213
Cochrane    n=   185
Total     n=3,672
Number of records after duplicates removed
           n=2,577
Number of records screened
        n=2,577
Number of records excluded     
after sceening title and 
abstracts
         n=2,513
Number of full-text articles 
assessed for eligibility
n=64
Number of full-text articles 
excluded
n=52
Number of studies included in 
qualitative synthesis
n=12
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and we were unable to derive an algorithm allowing clinicians 
to assess patients’ prognosis at early stages of the disease.
Results based on the included literature
To the best of our knowledge this is the first attempt system-
atically to identify and consolidate the prognostic factors 
that influence the course of CRPS 1. Despite broad inclusion 
criteria, only a small number of studies fulfilled our inclusion 
criteria. This suggests that prognostic aspects of CRPS 1 have 
received little attention in high-level methodological research.
Our findings are in line with the results of a recently pub-
lished Delphi survey (24). In the absence of evidence-based 
prognostic factors, the authors performed a survey aimed at 
reaching an expert consensus on poor prognostic factors in 
CRPS 1. The expert panel agreed on 49 items, which, in their 
opinion, are associated with poor prognosis in CRPS 1. These 
factors consisted primarily of clinical manifestations, such as 
sensory disturbances and cold skin temperature. For many 
factors, we found only weak (disease duration, comorbidities) 
or conflicting evidence (localization, initiating event). For 
example, consensus was reached that onset after a fracture is 
likely to result in a poor prognosis, whereas Sandroni et al. 
(7) found a higher resolution rate if CRPS 1 appeared after a 
fracture than after other triggering events.
Strengths and limitations
The strength of this study is the application of a robust sys-
tematic review methodology. A comprehensive review of the 
literature based on a broad search of all relevant databases and 
the additional search of bibliographies of included studies, re-
Study of Pain (IASP) criteria (4) (n = 2 (7, 12)). In one prospec-
tive and two retrospective studies no diagnostic criteria were 
reported (10, 14, 20).
Prognostic factors
A wide spectrum of outcome parameters were investigated, in-
cluding self-reported symptoms (7, 16, 18, 20), clinical severity 
scores (10, 15, 19), development of complications (17), duration 
of disease (14) and return to work (11, 12). The included studies 
revealed a total of 28 prognostic factors. Cold skin temperature 
(n = 5) (10, 12, 14, 17, 18) and the presence of sensory distur-
bances (n = 3) (15, 18, 19) appear to represent parameters associ-
ated with a poor prognosis of CRPS 1. For details see Table IV.
We found no study developing or validating a prognostic 
instrument to identify patients with poor CRPS 1 prognosis. 
Moreover, the evidence at hand did not allow a diagnostic 
algorithm to be developed. 
DISCUSSION
Main findings
This systematic review revealed a wide scatter of general 
prognostic factors in CRPS 1 that were sometimes contradic-
tory. Clinical manifestations, such as the presence of cold skin 
temperature (10, 12, 14, 17, 18) and sensory disturbances (15, 
18, 19), seem to represent parameters associated with a poor 
prognosis in CRPS 1. Only a few studies used reliable and 
validated measures to assess prognostic factors and co-factors 
that might influence the course of the condition. Therefore, no 
assumption can be made regarding the causality of these find-
ings. We failed to quantify and rank order prognostic parameters 
Table IV. Prognostic factors grouped within 7 clinical clusters
Cluster Positive prognostic factors Negative prognostic factors
Gender (n = 3) Female (17)
Male (10, 16)
Age (n = 3) Age at onset < 40 years (10)
Median age at onset 35 years (17)
Age at onset < 16 years (16)
Diagnosis (n = 1) Delayed diagnosis (> 2 months after initiating event) (10)
Initiating event (n = 5) Fracture (7)
Spontaneous onset CRPS (10)
Polytrauma (11)
Initiating event other than fracture (12)
Severe initial injury (15)
Localization (n = 4) Distal articular location (11, 15)
Upper extremity (12)
Lower extremity (17)
Clinical features (n = 19) Absence of sensory changes (7)
Swelling (7)
Disease duration (16)
Exercise-induced pain (14)
Sensory disturbances (15, 18, 19)
Initially cold skin temperature (17)
Cold skin temperature (10, 12, 14, 17, 18)
Complications (infection, ulcers, chronic oedema, dystonia, myoclonus) (17, 18)
Clinical algodystrophy score > 7 (7)
Low score on general health in SF-36 (16)
Disease duration > 1 year (20)
Coexistence of misdiagnosed nerve injury or compression (20)
Contextual factors (n = 2) Comorbidities (e.g. alcoholism) (11)
Psychological background in non-traumatic CRPS (13)
CRPS: complex regional pain syndrome.
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indicate that little is known about prognostic relevant factors 
predictive of an unfavourable course of the disease. Although 
epidemiological studies suggest that many mild forms of 
CRPS 1 resolve spontaneously (7), it is clinically important 
and relevant to recognize prognostic factors associated with 
unfavourable outcome. Timely identification of negative pre-
dictors will most likely lead to early referral for current best 
practice treatment and therefore better treatment outcome. One 
promising method could be a severity score (28), which may 
help guide treatment intensity. However, to date, the impact 
of such a score on treatment outcome is unknown and requires 
further investigation.
In addition, as our systematic review highlights, nearly all 
prognostic factors identified in the Delphi Survey (24) are 
currently not, or are only weakly, supported by the existing 
evidence, and therefore further research is needed. Based on 
our review, patients with clinical features including sensory 
disturbances and cold CRPS 1 are likely to have an unfavour-
able course of disease and should be treated aggressively. 
Physicians treating patients with CRPS 1 are therefore strongly 
encouraged to include patients in a registry in order to further 
enhance our knowledge about the disease. 
Conclusion
In conclusion, this systematic review highlights the need 
for studies investigating prognostic factors for the course of 
CRPS 1 that allow clinicians to define a specific risk profile in 
patients. The current evidence is weak, and consistency was 
found only for negative predictive features, such as sensory 
disturbances and cold skin temperature. These findings are in 
agreement with a consensus on poor prognostic factors reached 
by an expert panel. However, for many other proposed relevant 
factors, we were unable to identify evidence to support their 
influence on the course of the disease. We presume that this 
finding is due to lack of evidence regarding the aetiological 
and prognostic understanding of CRPS 1. Further research 
should therefore aim to investigate the clinical value of factors 
believed to be of importance both for the development and the 
course of the disease.
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